Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18902544 | 1.00 | HTT (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL4482068 | 0.97 | HTT (0.44) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL3966692 | 0.95 | HTT (0.56) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL17137852 | 0.92 | HTT (0.52) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL874663 | 0.91 | TSHR (0.43) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL627684 | 0.91 | TSHR (0.43) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL28218907 | 0.91 | HTT (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL760952 | 0.91 | HTT (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL25996482 | 0.91 | HTT (0.48) | HTTMEN1THRBKMT2AMAPT | |
| SCHEMBL11759255 | 0.91 | HTT (0.48) | HTTMEN1THRBKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022098990-A1 | TARGETED CONJUGATES COMPRISING MODIFIED SIRNA | ARBUTUS BIOPHARMA CORPORATION (CA) | 2022-05-12 | — | — | WO | disclosed |